- Scientists map fat growth inside muscles for the first time
- Could help millions with obesity, diabetes, or heart disease
- Still in labs—years from clinics
This discovery could change how we treat metabolic disease.
You wake up, take your morning walk, and feel heavier than usual. Not just in weight—but in how your body moves. Your legs feel stiff. Your energy dips fast. You’re doing everything “right,” but something’s off. What if the problem isn’t just fat under your skin—but fat inside your muscles?
That hidden fat—called intermuscular fat—has long been linked to diabetes, heart disease, and weakness as we age. Doctors see it on scans and know it’s bad news. But they haven’t known how it forms. Or how to stop it. Until now.
Millions of people struggle with metabolic disease. This includes type 2 diabetes, high blood pressure, and heart problems tied to weight and inactivity. A hidden player in all of this? Fat that builds up between muscle fibers.
It’s not the fat you can pinch. It’s deeper. Sneaky. And it changes how muscles work. The more of it you have, the higher your risk for serious health issues. Older adults, people with obesity, and those with insulin resistance are especially affected.
Current treatments focus on diet, exercise, and managing blood sugar. But they don’t target this internal fat directly. And no drug exists to stop it from forming. That’s why this research is such a big deal.
The surprising shift
For years, scientists thought fat in muscles came from a steady overflow. Like a bathtub filling up—too many calories, and fat cells just grow everywhere, including inside muscles.
But here’s the twist: this study shows it’s not a flood. It’s more like construction zones. Tiny neighborhoods inside the muscle where fat forms in a very organized way.
What scientists didn’t expect
These “construction zones” aren’t random. They’re specific spots around muscle fibers where certain cells wake up and change jobs. Cells that should help repair muscle start turning into fat instead.
And it’s not just one signal. It’s a full team effort: inflammation, scar tissue, metabolism—all switching on together in the same small area.
A switch inside your cells
Think of your body like a city. Muscle fibers are highways. When damage happens, repair crews (called fibro-adipogenic progenitors, or FAPs) rush in. Normally, they help fix the road.
But under constant stress—like poor diet or aging—something flips. It’s like the repair crew gets new orders. Instead of fixing the highway, they start building parking lots. Fat takes over.
One key player? A gene switch called EBF2. When turned on, it tells cells: “Become fat.” In lab tests, flipping this switch in human muscle cells was enough to start the change.
This doesn’t mean this treatment is available yet.
What they saw in the lab
Researchers used mice fed a high-fat diet to mimic human metabolic disease. They mapped gene activity in muscle tissue with a new tool called spatial transcriptomics—like GPS for genes.
This let them see exactly where fat was forming and which genes were active in each tiny spot.
They found fat didn’t spread evenly. It grew in clusters—niches—where multiple harmful pathways turned on at once. Adipogenic (fat-forming) genes. Inflammatory signals. Scar-forming cells. All working together.
The human link
Even better—the same gene patterns showed up in human tissue. The EBF2 switch was active in people with high intermuscular fat. When scientists tested it in human muscle cells in a dish, turning on EBF2 caused them to become fat-like.
This cross-check between mice and humans makes the findings much stronger. It means the mouse model reflects real human disease.
But there’s a catch.
Even though these “repair” cells (FAPs) are present, their numbers didn’t predict fat growth. That means it’s not about how many cells are there—it’s about what they’re doing and where.
Context matters. A cell might repair in one area and turn to fat in another. This changes how we think about treatment. We can’t just target cell numbers. We have to change their environment.
Why this changes the game
“This shows fat in muscle isn’t a passive result of overeating,” says one researcher familiar with the work. “It’s an active process—driven by cell reprogramming in specific zones.”
That means future drugs could aim to block that reprogramming. Or flip the switch back. Not by attacking fat, but by guiding cells to stay on repair duty.
Right now, this is still in the lab. No drug targets EBF2 or these muscle niches yet. You can’t get tested for it. And no supplement will turn it off.
But it gives scientists a clear path forward. For patients, it offers hope: one day, doctors may treat metabolic disease by protecting muscle from internal fat.
For now, the best tools remain diet, movement, and managing blood sugar. But this research could lead to more precise treatments down the road.
The limits of the study
The work was done mostly in mice. Human cell tests were in dishes, not bodies. The spatial mapping is powerful, but it’s a snapshot—not a movie of how fat grows over time.
Also, while EBF2 is a strong candidate, it’s likely not the only switch involved. The body is complex. Many genes and signals may play supporting roles.
What happens next
Scientists will now look for ways to block EBF2 safely. They’ll test if turning it off in mice prevents fat buildup and improves muscle function. If successful, drug companies may start designing molecules to target it.
Human trials are still years away. But for the first time, researchers can see the battlefield—and the enemy’s playbook.
The road ahead is long—but now we know where to start.
